US 8592596
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
granted A61KA61K31/4465A61P
Quick answer
US patent 8592596 (Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound) held by Theravance, Inc. expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/4465, A61P, A61P11/06, A61P13/00